Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

PET Biomarker Study for Antidepressant Response Prediction in Major Depressive Disorder

NCT06452290 is registered in ClinicalTrials.gov with Central Hospital, Nancy, France as lead sponsor.

NCT NCT06452290
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06452290 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
PET Biomarker Study for Antidepressant Response Prediction in Major Depressive Disorder
Lead sponsor
Central Hospital, Nancy, France
Phase
Not applicable
Overall status
Not yet recruiting
Start date
September 1, 2026
Completion date
March 1, 2029
Enrollment
30 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

major depressive disorder